Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewCardiology Open Access | 10.1172/jci.insight.196619

PhIP-Seq uncovers marked heterogeneity in Acute Rheumatic Fever Autoantibodies

Reuben McGregor,1 Lauren H. Carlton,1 Timothy J. O'Donnell,2 Elliot Merritt,2 Campbell R. Sheen,3 Florina Chan Mow,4 William John Martin,5 Michael G. Baker,6 Nigel Wilson,7 Uri Laserson,2 and Nicole J. Moreland1

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by McGregor, R. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Carlton, L. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by O'Donnell, T. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Merritt, E. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Sheen, C. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Chan Mow, F. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Martin, W. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Baker, M. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Wilson, N. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Laserson, U. in: PubMed | Google Scholar

1Department of Molecular Medicine, The University of Auckland, Auckland, New Zealand

2Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, United States of America

3Canterbury Health Laboratories, Christchurch, NZ & Biomolecular Interaction, University of Canterbury, Christchurch, New Zealand

4Te Whatu Ora–Health New Zealand, Auckland, New Zealand

5Independent Advisor, Wellington, New Zealand

6Department of Public Health, University of Otago, Wellington, New Zealand

7Starship Children’s Hospital, Health New Zealand – Te Whatu Ora, Auckland, New Zealand

8Department of Molecular Medicine, The University of Auckland, Aucklund, New Zealand

Find articles by Moreland, N. in: PubMed | Google Scholar

Published November 18, 2025 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.196619.
Copyright © 2025, McGregor et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 18, 2025 - Version history
View PDF
Abstract

Acute rheumatic fever (ARF) and associated rheumatic heart disease are serious sequelae of a Group A Streptococcus (GAS/Strep A) infection. Autoantibodies are thought to contribute to pathogenesis, with deeper exploration of the autoantibody repertoire needed to improve mechanistic understanding and identify new biomarkers. Phage immunoprecipitation and Sequencing (PhIP-Seq) with the HuScan library (>250,000 overlapping 90-mer peptides spanning the human proteome) was utilised to analyse autoreactivity in sera from children with ARF, uncomplicated Strep A pharyngitis and matched healthy controls. A global proteome-wide increase in autoantigen reactivity was observed in ARF, as was marked heterogeneity between patients. Public epitopes, common between individuals with ARF were rare, and comprised < 1% of all enriched peptides. Differential analysis identified both novel and previously identified ARF autoantigens, including PPP1R12B, a myosin phosphatase complex regulatory subunit expressed in cardiac muscle, and members of the collagen-protein family, respectively. Pathway analysis found antigens from the disease-relevant processes encompassing sarcomere and heart-morphogenesis were targeted. In sum, PhIP-Seq has substantially expanded the spectrum of autoantigens in ARF, and reveals the rarity of public epitopes in the disease. It provides further support for the role of epitope spreading in pathogenesis and has identified PPP1R12B as a novel, enriched autoantigen.

Graphical Abstract
graphical abstract
Supplemental material

View Supplementary data

View

Version history
  • Version 1 (November 18, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts